Seeking Alpha

NHLBI awards final $1.9M of grant to Discovery Labs

  • The National Heart, Lung and Blood Institute (NHLBI) awards the remainder of a Fast Track Small Business Innovation Grant to Discovery Labs (DSCO +1.2%). The $2.4M total grant provided support for the development and Phase 2a clinical trial of Aerosurf, the company's investigational drug/device combination product for respiratory distress syndrome in premature infants. It provides KL4 surfactant therapy through nasal continuous positive airway pressure and enables the infant to potentially avoid endotracheal intubation.
Comments (2)
  • grantdon
    , contributor
    Comment (1) | Send Message
    Hopefully, this will be looked upon as a signal that things are looking up for DSCO
    17 Jun, 09:06 PM Reply Like
  • kdII
    , contributor
    Comments (235) | Send Message
    Getting no love. Odd. Of course, if approved, Aerosurf won't hit the market until 2018. Still way out. Hopefully, they will get fast track.
    27 Jun, 03:07 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: